A detailed history of Trexquant Investment LP transactions in Bioventus Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 44,471 shares of BVS stock, worth $404,241. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,471
Previous 102,964 56.81%
Holding current value
$404,241
Previous $1.23 Million 62.11%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$10.5 - $13.71 $614,176 - $801,939
-58,493 Reduced 56.81%
44,471 $466,000
Q3 2024

Nov 12, 2024

BUY
$5.73 - $11.95 $589,983 - $1.23 Million
102,964 New
102,964 $1.23 Million

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $561M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.